Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Isolation of flavonol rhamnosides from Pometia pinnata leaves and investigation of α-glucosidase inhibitory activity of flavonol derivatives

Fadhila Utari ,Afrizal Itam,Syafrizayanti Syafrizayanti,Widya Hasvini Putri,Masayuki Ninomiya,Mamoru Koketsu,Kaori Tanaka,Mai Efdi.




Abstract
Cited by 13 Articles

Pometia pinnata belonging to the Sapindaceae family has been traditionally used as the therapeutic agent for burns and wounds in Indonesia. Based on the result of experiment conducted, the ethyl acetate fraction of P. pinnata leaves showed strong α-glucosidase inhibitory activity. After two flavonol rhamnoside compounds were isolated from ethyl acetate fraction of P. pinnata leaves methanol extract using chromatography method, their structures were identified as kaempferol-3-O-rhamnoside (1) and quercetin-3-O-rhamnoside (2). The UPLC-ESI-TOFMS chromatogram showed compounds 1 and 2 were the major compounds of the ethyl acetate fraction. In this study, the structure-activity relationship among the kaempferol, quercetin and their derivatives bearing sugar moiety were also evaluated. Among tested eight compounds, kaempferol 7 (percent inhibition = 80.10% ± 0.8) and quercetin 8 (percent inhibition = 82.93% ± 0.4) had stronger α-glucosidase inhibitory activity than that of other derivatives. Among kaempferol derivatives bearing sugar moiety, compound 1 showed the strongest activity. Moreover, compound 2 showed strong α-glucosidase inhibitory activity among quercetin derivatives. Therefore, it can be confirmed that the hydroxyl group at C-3 position is very important for α-glucosidase inhibitory activity of flavonol compounds.

Key words: Pometia pinnata, α-glucosidase inhibitory, kaempferol-3-O-rhamnoside, quercetin-3-O-rhamnoside, UPLC-ESI-TOFMS






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.